請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45573
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 謝學真 | |
dc.contributor.author | Ya-Hsi Hwang | en |
dc.contributor.author | 黃雅希 | zh_TW |
dc.date.accessioned | 2021-06-15T04:28:00Z | - |
dc.date.available | 2012-08-20 | |
dc.date.copyright | 2009-08-20 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-08-20 | |
dc.identifier.citation | 1. Langer, R., and Vacanti, J.P. (1993). Tissue engineering. Science 260, 920-926.
2. Yeh, L.C.C., Tsai, A.D., and Lee, J.C. (2002). Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. Journal of Cellular Biochemistry 87, 292-304. 3. Rickard, D.J., Sullivan, T.A., Shenker, B.J., Leboy, P.S., and Kazhdan, I. (1994). Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161, 218-228. 4. Byers, B.A., Guldberg, R.E., and Garcia, A.J. (2004). Synergy between genetic and tissue engineering: Runx2 overexpression and in vitro construct development enhance in vivo mineralization. Tissue Engineering 10, 1757-1766. 5. Tu, Q., Valverde, P., and Chen, J. (2006). Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem Biophys Res Commun 341, 1257-1265. 6. Weissman, I.L., Anderson, D.J., and Gage, F. (2001). Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Annual Review of Cell and Developmental Biology 17, 387-403. 7. Smith, A.G. (2001). Self-renewal and differentiation of pluripotent embryonic stem cells. Developmental Biology 235, 289-290. 8. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., and Jones, J.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147. 9. Spangrude, G.J., Heimfeld, S., and Weissman, I.L. (1988). Purification and characterization of mouse hematopoietic stem cells. Science 241, 58-62. 10. Kato, K., and Radbruch, A. (1993). Isolation and characterization of CD34+ hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting. Cytometry 14, 384-392. 11. Conget, P.A., and Minguell, J.J. (1999). Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181, 67-73. 12. Guo, Z., Yang, J., Liu, X., Li, X., Hou, C., Tang, P.H., and Mao, N. (2001). Biological features of mesenchymal stem cells from human bone marrow. Chin Med J (Engl) 114, 950-953. 13. Pagano, S.F., Impagnatiello, F., Girelli, M., Cova, L., Grioni, E., Onofri, M., Cavallaro, M., Etteri, S., Vitello, F., Giombini, S., Solero, C.L., and Parati, E.A. (2000). Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 18, 295-300. 14. Li, X., Xu, J., Bai, Y., Wang, X., Dai, X., Liu, Y., Zhang, J., Zou, J., Shen, L., and Li, L. (2005). Isolation and characterization of neural stem cells from human fetal striatum. Biochem Biophys Res Commun 326, 425-434. 15. Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Locatelli, F., Papadimitriou, D., Salani, S., Del Bo, R., Ghezzi, S., Strazzer, S., Bresolin, N., and Comi, G.P. (2007). Isolation and characterization of murine neural stem/progenitor cells based on Prominin-1 expression. Exp Neurol 205, 547-562. 16. Schlotzer-Schrehardt, U., and Kruse, F.E. (2005). Identification and characterization of limbal stem cells. Exp Eye Res 81, 247-264. 17. Shortt, A.J., Secker, G.A., Munro, P.M., Khaw, P.T., Tuft, S.J., and Daniels, J.T. (2007). Characterization of the limbal epithelial stem cell niche: novel imaging techniques permit in vivo observation and targeted biopsy of limbal epithelial stem cells. Stem Cells 25, 1402-1409. 18. Trosko, J.E., and Chang, C.C. (2003). Isolation and characterization of normal adult human epithelial pluripotent stem cells. Oncol Res 13, 353-357. 19. Boheler, K.R., Czyz, J., Tweedie, D., Yang, H.T., Anisimov, S.V., and Wobus, A.M. (2002). Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91, 189-201. 20. Friedenstein, A.J., Gorskaja, J.F., and Kulagina, N.N. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4, 267-274. 21. Bruder, S.P., Jaiswal, N., and Haynesworth, S.E. (1997). Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64, 278-294. 22. Caplan, A.I. (1991). Mesenchymal stem cells. J Orthop Res 9, 641-650. 23. Mets, T., and Verdonk, G. (1981). In vitro aging of human bone marrow derived stromal cells. Mech Ageing Dev 16, 81-89. 24. Zohar, R., Sodek, J., and McCulloch, C.A. (1997). Characterization of stromal progenitor cells enriched by flow cytometry. Blood 90, 3471-3481. 25. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. 26. Theise, N.D., Nimmakayalu, M., Gardner, R., Illei, P.B., Morgan, G., Teperman, L., Henegariu, O., and Krause, D.S. (2000). Liver from bone marrow in humans. Hepatology 32, 11-16. 27. Alison, M.R., Poulsom, R., Jeffery, R., Dhillon, A.P., Quaglia, A., Jacob, J., Novelli, M., Prentice, G., Williamson, J., and Wright, N.A. (2000). Hepatocytes from non-hepatic adult stem cells. Nature 406, 257. 28. Petersen, B.E., Bowen, W.C., Patrene, K.D., Mars, W.M., Sullivan, A.K., Murase, N., Boggs, S.S., Greenberger, J.S., and Goff, J.P. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284, 1168-1170. 29. Wang, J.S., Shum-Tim, D., Galipeau, J., Chedrawy, E., Eliopoulos, N., and Chiu, R.C. (2000). Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120, 999-1005. 30. Orlic, D., Kajstura, J., Chimenti, S., Bodine, D.M., Leri, A., and Anversa, P. (2003). Bone marrow stem cells regenerate infarcted myocardium. Pediatric Transplantation 7, 86-88. 31. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., Leri, A., and Anversa, P. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705. 32. Black, I.B., and Woodbury, D. (2001). Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells Molecules and Diseases 27, 632-636. 33. Woodbury, D., Schwarz, E.J., Prockop, D.J., and Black, I.B. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of Neuroscience Research 61, 364-370. 34. Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C., Stedeford, T., Willing, A., Freeman, T.B., Saporta, S., Janssen, W., Patel, N., Cooper, D.R., and Sanberg, P.R. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Experimental Neurology 164, 247-256. 35. (2009). Essentials of stem cell biology (London :: Academic). 36. Mareschi, K., Biasin, E., Piacibello, W., Aglietta, M., Madon, E., and Fagioli, F. (2001). Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 86, 1099-1100. 37. Lin, H.R., Chen, K.S., Chen, S.C., Lee, C.H., Chiou, S.H., Chang, T.L., and Wu, T.H. (2007). Attachment of stem cells on porous chitosan scaffold crosslinked by Na5P3O10. Materials Science & Engineering C-Biomimetic and Supramolecular Systems 27, 280-284. 38. Anfosso, F., Bardin, N., Vivier, E., Sabatier, F., Sampol, J., and Dignat-George, F. (2001). Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem 276, 1564-1569. 39. Minguell, J.J., Erices, A., and Conget, P. (2001). Mesenchymal stem cells. Experimental Biology and Medicine 226, 507-520. 40. Hung, S.C., Yang, D.M., Chang, C.F., Lin, R.J., Wang, J.S., Low-Tone Ho, L., and Yang, W.K. (2004). Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes. Int J Cancer 110, 313-319. 41. Cohen, B.J. (2004). Medical terminology (Philadelphia :: Lippincott Williams & Wilkins). 42. Miura, M., Gronthos, S., Zhao, M., Lu, B., Fisher, L.W., Robey, P.G., and Shi, S. (2003). SHED - Stem cells from human exfoliated deciduous teeth. Journal of Dental Research 82, 2358. 43. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and Shi, S. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97, 13625-13630. 44. Gronthos, S., Zannettino, A.C., Hay, S.J., Shi, S., Graves, S.E., Kortesidis, A., and Simmons, P.J. (2003). Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116, 1827-1835. 45. Nor, J.E. (2006). Tooth regeneration in operative dentistry. Oper Dent 31, 633-642. 46. Shi, S., and Gronthos, S. (2003). Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18, 696-704. 47. Seo, B.M., Miura, M., Gronthos, S., Bartold, P.M., Batouli, S., Brahim, J., Young, M., Robey, P.G., Wang, C.Y., and Shi, S. (2004). Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364, 149-155. 48. Miura, M., Chen, X.D., Allen, M.R., Bi, Y., Gronthos, S., Seo, B.M., Lakhani, S., Flavell, R.A., Feng, X.H., Robey, P.G., Young, M., and Shi, S. (2004). A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest 114, 1704-1713. 49. Ivanovski, S., Haase, H.R., and Bartold, P.M. (2001). Expression of bone matrix protein mRNAs by primary and cloned cultures of the regenerative phenotype of human periodontal fibroblasts. J Dent Res 80, 1665-1671. 50. Bartold, P.M., Moule, A.J., Li, H., and Rigby, P. (1995). Isolation and characterization of the proteoglycans synthesized by adult human pulp fibroblasts in vitro. Int Endod J 28, 163-171. 51. Bartold, P.M., Reinboth, B., Nakae, H., Narayanan, A.S., and Page, R.C. (1990). Proteoglycans of bovine cementum: isolation and characterization. Matrix 10, 10-19. 52. Cordeiro, M.M., Dong, Z., Kaneko, T., Zhang, Z., Miyazawa, M., Shi, S., Smith, A.J., and Nor, J.E. (2008). Dental pulp tissue engineering with stem cells from exfoliated deciduous teeth. J Endod 34, 962-969. 53. Shi, S., Bartold, P.M., Miura, M., Seo, B.M., Robey, P.G., and Gronthos, S. (2005). The efficacy of mesenchymal stem cells to regenerate and repair dental structures. Orthod Craniofac Res 8, 191-199. 54. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. (1997). Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Journal of Cellular Biochemistry 64, 295-312. 55. Graves, S.E., Francis, M.J.O., Gundle, R., and Beresoford, J.N. (1994a). Primary culture of human trabecular bone: Effects of L-ascorbate-2-phosphate. . Bone 15, 132-133. 56. Graves, S.E., Francis, M.J.O., and Beresoford, J.N. (1994b). Ascorbate increases collagen synthesis and promote differentiation in human bone derived cell cultures. Bone 15, 132-133. 57. Vukicevic, S., Luyten, F.P., and Reddi, A.H. (1989). Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci U S A 86, 8793-8797. 58. Jorgensen, N.R., Henriksen, Z., Sorensen, O.H., and Civitelli, R. (2004). Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69, 219-226. 59. Kamalia, N., McCulloch, C.A., Tenebaum, H.C., and Limeback, H. (1992). Dexamethasone recruitment of self-renewing osteoprogenitor cells in chick bone marrow stromal cell cultures. Blood 79, 320-326. 60. Jorgensen, N.R., Henriksen, Z., Sorensen, O.H., and Civitelli, R. (2004). Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69, 219-226. 61. Wang, L., Zhao, R., Shi, X., Wei, T., Halloran, B.P., Clark, D.J., Jacobs, C.R., and Kingery, W.S. (2009). Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone 45, 309-320. 62. Byers, B.A., Guldberg, R.E., and Garcia, A.J. (2004). Synergy between genetic and tissue engineering: Runx2 overexpression and in vitro construct development enhance in vivo mineralization. Tissue Eng 10, 1757-1766. 63. 陳柏仰 (2007). 透明質酸及含氫氧基磷灰石之膠原蛋白複合基質對於脂肪基質細胞增生及骨分化潛能之效應. 64. Meinel, L., Karageorgiou, V., Fajardo, R., Snyder, B., Shinde-Patil, V., Zichner, L., Kaplan, D., Langer, R., and Vunjak-Novakovic, G. (2004). Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 32, 112-122. 65. Alberti, K., Davey, R.E., Onishi, K., George, S., Salchert, K., Seib, F.P., Bornhauser, M., Pompe, T., Nagy, A., Werner, C., and Zandstra, P.W. (2008). Functional immobilization of signaling proteins enables control of stem cell fate. Nat Methods 5, 645-650. 66. Ohgushi, H., Dohi, Y., Tamai, S., and Tabata, S. (1993). Osteogenic differentiation of marrow stromal stem cells in porous hydroxyapatite ceramics. J Biomed Mater Res 27, 1401-1407. 67. Lane, J.M., Yasko, A.W., Tomin, E., Cole, B.J., Waller, S., Browne, M., Turek, T., and Gross, J. (1999). Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop Relat Res, 216-227. 68. Mikos, A.G., McIntire, L.V., Anderson, J.M., and Babensee, J.E. (1998). Host response to tissue engineered devices. Adv Drug Deliv Rev 33, 111-139. 69. 顎律編 (2001). 組織培養和分子細胞學技術 (北京出版社). 70. Kas, H.S. (1997). Chitosan: properties, preparations and application to microparticulate systems. J Microencapsul 14, 689-711. 71. Chen, P.H., Kuo, T.Y., Liu, F.H., Hwang, Y.H., Ho, M.H., Wang, D.M., Lai, J.Y., and Hsieh, H.J. (2008). Use of dicarboxylic acids to improve and diversify the material properties of porous chitosan membranes. Journal of Agricultural and Food Chemistry 56, 9015-9021. 72. Illum, L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharmaceutical Research 15, 1326-1331. 73. Amass, W., Amass, A., and Tighe, B. (1998). A review of biodegradable polymers: Uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies. Polymer International 47, 89-144. 74. Kumar, M.N.V.R. (2000). A review of chitin and chitosan applications. Reactive & Functional Polymers 46, 1-27. 75. Klokkevold, P.R., Subar, P., Fukayama, H., and Bertolami, C.N. (1992). Effect of Chitosan on Lingual Hemostasis in Rabbits with Platelet Dysfunction Induced by Epoprostenol. Journal of Oral and Maxillofacial Surgery 50, 41-45. 76. Muzzarelli, R.A.A., Zucchini, C., Ilari, P., Pugnaloni, A., Belmonte, M.M., Biagini, G., and Castaldini, C. (1993). Osteoconductive Properties of Methylpyrrolidinone Chitosan in an Animal-Model. Biomaterials 14, 925-929. 77. Fakhry, A., Schneider, G.B., Zaharias, R., and Senel, S. (2004). Chitosan supports the initial attachment and spreading of osteoblasts preferentially over fibroblasts. Biomaterials 25, 2075-2079. 78. Muzzarelli, R.A.A. (1993). Biochemical Significance of Exogenous Chitins and Chitosans in Animals and Patients. Carbohydrate Polymers 20, 7-16. 79. Muzzarelli, R.A.A., Mattiolibelmonte, M., Tietz, C., Biagini, R., Ferioli, G., Brunelli, M.A., Fini, M., Giardino, R., Ilari, P., and Biagini, G. (1994). Stimulatory Effect on Bone-Formation Exerted by a Modified Chitosan. Biomaterials 15, 1075-1081. 80. Borah, G., Scott, G., and Wortham, K. (1992). Induction by chitosan in endochondral bones of the extrmities. In 5th International Conference on Chitin and Chitosan, Elsevier: Amsterdan. 81. Sechriest, V.F., Miao, Y.J., Niyibizi, C., Westerhausen-Larson, A., Matthew, H.W., Evans, C.H., Fu, F.H., and Suh, J.K. (2000). GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis. J Biomed Mater Res 49, 534-541. 82. Senkoylu, A., Simsek, A., Sahin, F.I., Menevse, S., Ozogul, C., Denkbas, E.B., and Piskin, E. (2001). Interaction of cultured chondrocytes with chitosan scaffold. Journal of Bioactive and Compatible Polymers 16, 136-144. 83. Lahiji, A., Sohrabi, A., Hungerford, D.S., and Frondoza, C.G. (2000). Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. Journal of Biomedical Materials Research 51, 586-595. 84. Le Trong, I., McDevitt, T.C., Nelson, K.E., Stayton, P.S., and Stenkamp, R.E. (2003). Structural characterization and comparison of RGD cell-adhesion recognition sites engineered into streptavidin. Acta Crystallogr D Biol Crystallogr 59, 828-834. 85. Yang, X.B., Bhatnagar, R.S., Li, S., and Oreffo, R.O. (2004). Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 10, 1148-1159. 86. Gu, Q. (2006). [Clinical application of collagen]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 20, 1052-1058. 87. McCarthy, J.B., Vachhani, B., and Iida, J. (1996). Cell adhesion to collagenous matrices. Biopolymers 40, 371-381. 88. Friess, W. (1998). Collagen--biomaterial for drug delivery. Eur J Pharm Biopharm 45, 113-136. 89. Rocha, L.B., Goissis, G., and Rossi, M.A. (2002). Biocompatibility of anionic collagen matrix as scaffold for bone healing. Biomaterials 23, 449-456. 90. Franceschi, R.T., Iyer, B.S., and Cui, Y.Q. (1994). Effects of Ascorbic-Acid on Collagen Matrix Formation and Osteoblast Differentiation in Murine Mc3t3-E1 Cells. Journal of Bone and Mineral Research 9, 843-854. 91. Otsuka, E., Yamaguchi, A., Hirose, S., and Hagiwara, H. (1999). Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. American Journal of Physiology-Cell Physiology 277, C132-C138. 92. Azuma, H., Kido, J., Ikedo, D., Kataoka, M., and Nagata, T. (2004). Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from Porphyromonas gingivalis. J Periodontol 75, 974-981. 93. Pearson, J., Dancis, J., Axelrod, F., and Grover, N. (1975). The sural nerve in familial dysautonomia. J Neuropathol Exp Neurol 34, 413-424. 94. Maayan, C., Bar-On, E., Foldes, A.J., Gesundheit, B., and Pollak, R.D. (2002). Bone mineral density and metabolism in familial dysautonomia. Osteoporos Int 13, 429-433. 95. Bjurholm, A., Kreicbergs, A., Schultzberg, M., and Lerner, U.H. (1992). Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J Bone Miner Res 7, 1011-1019. 96. Liu, F., Malaval, L., and Aubin, J.E. (2003). Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J Cell Sci 116, 1787-1796. 97. Takahashi, T., Lord, B., Schulze, P.C., Fryer, R.M., Sarang, S.S., Gullans, S.R., and Lee, R.T. (2003). Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107, 1912-1916. 98. Lee, J.Y., Choo, J.E., Choi, Y.S., Shim, I.K., Lee, S.J., Seol, Y.J., Chung, C.P., and Park, Y.J. (2009). Effect of immobilized cell-binding peptides on chitosan membranes for osteoblastic differentiation of mesenchymal stem cells. Biotechnol Appl Biochem 52, 69-77. 99. Lim, T.Y., Wang, W., Shi, Z., Poh, C.K., and Neoh, K.G. (2009). Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2. J Mater Sci Mater Med 20, 1-10. 100. Park, Y.J., Lee, Y.M., Lee, J.Y., Seol, Y.J., Chung, C.P., and Lee, S.J. (2000). Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. Journal of Controlled Release 67, 385-394. 101. Shi, Z., Neoh, K.G., Kang, E.T., Poh, C.K., and Wang, W. (2009). Surface Functionalization of Titanium with Carboxymethyl Chitosan and Immobilized Bone Morphogenetic Protein-2 for Enhanced Osseointegration. Biomacromolecules 10, 1603-1611. 102. Michael, S.P., Robert, M.S., Sudha, K., and Frank, P.B. (2000). Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. Journal of Biomedical Materials Research 52, 246-255. 103. Pemg, C.K., Kao, C.L., Yang, Y.P., Lin, H.T., Lin, W.B., Chu, Y.R., Wang, H.J., Ma, H., Ku, H.H., and Chiou, S.H. (2008). Culturing adult human bone marrow stem cells on gelatin scaffold with pNIPAAm as transplanted grafts for skin regeneration. Journal of Biomedical Materials Research Part A 84A, 622-630. 104. Xuechao, Y., Fang, Y., Walboomers, X.F., Zhuan, B., Mingwen, F., and John, A.J. (2009). The performance of dental pulp stem cells on nanofibrous PCL/gelatin/nHA scaffolds. Journal of Biomedical Materials Research Part A 9999, NA. 105. Mojgan, Z., Hamid, M., Christian, M., Henning, U., Mohamadreza Baghaban, E., Fatemeh, B., and Houri, M. (2009). Biocompatibility evaluation of nano-rod hydroxyapatite/gelatin coated with nano-HAp as a novel scaffold using mesenchymal stem cells. Journal of Biomedical Materials Research Part A 9999, NA. 106. Zhao, F., Grayson, W.L., Ma, T., Bunnell, B., and Lu, W.W. (2006). Effects of hydroxyapatite in 3-D chitosan-gelatin polymer network on human mesenchymal stem cell construct development. Biomaterials 27, 1859-1867. 107. Zhao, F., Yin, Y., Lu, W.W., Leong, J.C., Zhang, W., Zhang, J., Zhang, M., and Yao, K. (2002). Preparation and histological evaluation of biomimetic three-dimensional hydroxyapatite/chitosan-gelatin network composite scaffolds. Biomaterials 23, 3227-3234. 108. Machado, C.B., Ventura, J.M., Lemos, A.F., Ferreira, J.M., Leite, M.F., and Goes, A.M. (2007). 3D chitosan-gelatin-chondroitin porous scaffold improves osteogenic differentiation of mesenchymal stem cells. Biomed Mater 2, 124-131. 109. Mohammadi, Y., Mirzadeh, H., Moztarzadeh, F., Soleimani, M., and Jabbari, E. (2007). Osteogenic differentiation of mesenchymal stem cells on novel three-dimensional poly(L-lactic acid)/chitosan/gelatin/beta-tricalcium phosphate hybrid scaffolds. Iranian Polymer Journal 16, 57-69. 110. Lei, M., Liu, S.Q., and Liu, Y.L. (2008). Resveratrol protects bone marrow mesenchymal stem cell derived chondrocytes cultured on chitosan-gelatin scaffolds from the inhibitory effect of interleukin-1beta. Acta Pharmacol Sin 29, 1350-1356. 111. Caplan, A.I. (1994). The mesengenic process. Clin Plast Surg 21, 429-435. 112. Kalfas, I.H. (2001). Principles of bone healing. Neurosurg Focus 10, E1. 113. Copenhaver, W.M., Kelly, D.E., and Wood, R.L. (1978). Bailey's Textbook of Histology, 17 Edition (Baltimore: Williams and Wilkins). 114. Fawcett, D.W. (1994). A Textbook of Histology. (New York: Chapman and Hall). 115. Shui, C., Spelsberg, T.C., Riggs, B.L., and Khosla, S. (2003). Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18, 213-221. 116. Owen, T.A., Aronow, M., Shalhoub, V., Barone, L.M., Wilming, L., Tassinari, M.S., Kennedy, M.B., Pockwinse, S., Lian, J.B., and Stein, G.S. (1990). Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143, 420-430. 117. Peng, Y., Kang, Q., Luo, Q., Jiang, W., Si, W., Liu, B.A., Luu, H.H., Park, J.K., Li, X., Luo, J., Montag, A.G., Haydon, R.C., and He, T.C. (2004). Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279, 32941-32949. 118. Karen, P., Rosalba, T., and Daisy, J. (2002). Sensitivity of a novel biotin-free detection reagent (powervision+) for immunohistochemistry. Journal of histotechnology 25, 247-250 119. Rotman, B., and Papermas.Bw (1966). Membrane Properties of Living Mammalian Cells as Studied by Enzymatic Hydrolysis of Fluorogenic Esters. Proceedings of the National Academy of Sciences of the United States of America 55, 134-&. 120. Ormerod, M.G. (2000). Flow cytometry : a practical approach, 3rd Edition (Oxford: Oxford University Press). 121. Prudencio, C., Abrantes, B., Lopes, I., and Tavares, M.A. (2002). Structural and functional cellular alterations underlying the toxicity of methamphetamine in rat retina and prefrontal cortex. Cellular and Molecular Mechanisms of Drugs of Abuse Ii: Cocaine, Substituted Amphetamines, Ghb, and Opiates 965, 522-528. 122. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V., and Di Lisa, F. (1999). Mitochondria and cell death. Mechanistic aspects and methodological issues (vol 264, pg 687, 1999). European Journal of Biochemistry 265, 847-847. 123. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254. 124. Mc, G.-R.S. (1958). Histochemical methods for calcium. J Histochem Cytochem 6, 22-42. 125. Gitelman, H.J. (1967). An Improved Automated Procedure for Determination of Calcium in Biological Specimens. Analytical Biochemistry 18, 521-&. 126. 張懿丹 (2008). 人類乳牙牙髓幹細胞於牙髓組織再生之應用, 台灣大學. 127. Christenson, R.H. (1997). Biochemical markers of bone metabolism: an overview. Clin Biochem 30, 573-593. 128. Camozzi, V., Tossi, A., Simoni, E., Pagani, F., Francucci, C.M., and Moro, L. (2007). Role of biochemical markers of bone remodeling in clinical practice. J Endocrinol Invest 30, 13-17. 129. Fleisch, H., and Neuman, W. (1961). [The role of phosphatase and polyphosphates in calcification of collagen.]. Helv Physiol Pharmacol Acta 19, C17-18. 130. Bancroft, G.N., Sikavitsas, V.I., van den Dolder, J., Sheffield, T.L., Ambrose, C.G., Jansen, J.A., and Mikos, A.G. (2002). Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci U S A 99, 12600-12605. 131. Boyan, B.D., Lohmann, C.H., Sisk, M., Liu, Y., Sylvia, V.L., Cochran, D.L., Dean, D.D., and Schwartz, Z. (2001). Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness. J Biomed Mater Res 55, 350-359. 132. Park, Y.J., Ku, Y., Chung, C.P., and Lee, S.J. (1998). Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. Journal of Controlled Release 51, 201-211. 133. Byers, R.J., Brown, J., Brandwood, C., Wood, P., Staley, W., Hainey, L., Freemont, A.J., and Hoyland, J.A. (1999). Osteoblastic differentiation and mRNA analysis of STRO-1-positive human bone marrow stromal cells using primary in vitro culture and poly (A) PCR. J Pathol 187, 374-381. 134. Stewart, K., Walsh, S., Screen, J., Jefferiss, C.M., Chainey, J., Jordan, G.R., and Beresford, J.N. (1999). Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 14, 1345-1356. 135. Ahdjoudj, S., Lasmoles, F., Oyajobi, B.O., Lomri, A., Delannoy, P., and Marie, P.J. (2001). Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem 81, 23-38. 136. Bianco, P., Riminucci, M., Gronthos, S., and Robey, P.G. (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19, 180-192. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45573 | - |
dc.description.abstract | 適當的細胞來源和擴增技術,以及良好的生醫材料對於組織工程的應用而言極為重要。本研究以骨組織工程為目標,針對細胞的來源,以及促骨組織工程生醫材料進行深入研究和探討。首先,以人類骨髓間葉幹細胞株 (bone marrow mesenchymal stem cell line,BMSC) 及人類乳牙牙髓幹細胞 (stem cells from human exfoliated deciduous teeth,SHED) 探討其在體外擴增之可行性;繼而開發一種能提供細胞生長、並引導及誘導骨質新生之生醫材料,以期能使用於骨骼重建。
本研究使用幾丁聚醣作為主體之生醫材料,部份材料另外添加動物明膠及維他命C (縮寫分別為:C (幾丁聚醣)、CG (幾丁聚醣/動物明膠)、C-A (幾丁聚醣/維他命C)、CG-A (幾丁聚醣/動物明膠/維他命C) ),再進行間葉幹細胞之培養。另外,由光學顯微鏡觀察細胞形態及測定細胞DNA總量,可發現添加動物明膠於生醫材料中可以改善細胞的貼附情形,並促進細胞增生。 其次,利用即時定量聚合酶連鎖反應 (real-time polymerase chain reaction,real-time PCR) 及流式細胞分析技術 (flow cytometry) 探討骨鈣素 (osteocalcin,OCN) 基因及蛋白質表現。在不更換骨分化誘導培養基 (osteogenic medium,OM) 之情況下,在不同生醫材料表面上培養BMSC之OCN基因表現量並沒有顯著的改變。但若更換為OM,並在CG-A上培養甚至會降低OCN基因表現。而在不更換為OM時,在C-A表面上培養SHED,其OCN的基因表現與更換為OM的結果相當。在OCN之蛋白質表現方面,在更換為OM的情況下,BMSC在TCPS表面上培養其OCN-positive 細胞約佔50 %,在C表面上佔1.8 %,在CG表面上佔9.8 %,在CG-A表面上佔11.0 %。而未更換為OM時,BMSC在CG-A表面上培養其OCN-positive細胞佔20.5 %,甚至比更換為OM時更多。當更換為OM時,SHED在TCPS表面上培養其OCN-positive細胞約佔7.6 %,在CG表面上佔10.0 %。 除了OCN的表現之外,本研究另外探討鹼性磷酸酶 (alkaline phosphatase,ALP) 之活性。結果顯示,BMSC在生醫材料上培養並分化後第三天ALP之活性達到極大值,而SHED則無明顯的趨勢。 在分化後骨細胞之功能性表現方面,利用Alizarin red S染色以及測定 鈣含量。培養於CG-A表面上分化21天的BMSC鈣含量較在TCPS表面上提高1.56倍,而SHED的鈣含量則是提高了50倍。在不更換為OM的條件下,培養在C-A表面上的SHED的鈣含量與更換為OM相當。 由實驗結果來看,動物明膠能促進細胞貼附。另外,將本來存在於骨分化誘導培養基 (OM) 中之維他命C固定於生醫材料上,與維他命C存在於培養基中的效應相似。當不更換為OM的情況下,在CG-A表面上培養細胞其OCN-positive細胞佔20.5 %,甚至比更換為OM並培養於CG-A表面上之細胞比例為高。當材料中存在維他命C (C-A及CG-A表面),BMSC及SHED之ALP活性均會提高,鈣含量亦會有顯著的提升。結果顯示,本研究所開發之生醫材料,對於骨組織工程應用上,十分具有潛力。 | zh_TW |
dc.description.abstract | Suitable cell sources with good expansion technique, as well as excellent biomaterials are important for tissue engineering applications. In this study, we aimed at the application of bone tissue engineering and the feasibility of in vitro expansion of bone marrow mesenchymal stem cell line (BMSC) and stem cells from human exfoliated deciduous teeth (SHED), and the development of biomaterials with osteoinductive characteristics.
First of all, chitosan-based biomaterials were prepared namely, C (chitosan), CG (chitosan/gelatin), C-A (chitosan/ascorbic acid), CG-A (chitosan /gelatin/ascorbic acid)). By using inverted microscopy and measuring the DNA quantity, we found that gelatin could improve cell adhesion, and thus improve the proliferation rate. In this study, we also used real-time PCR and flow cytometry to detect the gene and protein expression of osteocalcin (OCN). Adding ascorbic acid and gelatin to chitosan biomaterials had little effect on the gene expression of OCN in BMSC. When BMSC exposed to osteogenic stimulus (OS), the gene expression of OCN in BMSC cultured on CG-A would decrease. When there was no OS, the expression of OCN in SHED cultured on C-A approximated that cultured in osteogenic medium. When exposed to OS, BMSC cultured on TCPS were 50 % OCN-positive, on C 1.8 %, on CG 9.8 %, on CG-A 11.0 %; SHED cultured on TCPS were 7.6 % OCN-positive, on CG 10.0 %. When there was no OM, the OCN-positive BMSC cultured on CG-A was 20.5 %. In addition to the expression of OCN, we also measure the activity of alkaline phosphatase (ALP). We found that the activity of ALP peaking at the 3rd day after osteogenic differentiation, while SHED didn’t have this intendency. In addition to the gene and protein expression, we also measured the function of cultured cells by using Alizarin red S staining and the content of calcium of BMSC or SHED. When BMSC cultured on CG-A under OS, the content of calcium increased to 1.56 folds of BMSC cultured on TCPS. For the case of SHED, the increment was up to 50 folds. Even if there was NS, SHED cultured on C-A still had similar amounts of calcium content. We demonstrated that the adsorption of ascorbic acid onto biomaterials had effect similar to the presence of ascorbic acid in medium. When there was NS, the OCN-positive BMSC cultured on CG-A was 20.5 %. These biomaterials (C-A and CG-A) enhanced the activity of ALP, and increased the content of calcium. Therefore, these biomaterials could be good candidates for bone-related tissue engineering applications. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T04:28:00Z (GMT). No. of bitstreams: 1 ntu-98-R96524074-1.pdf: 4250796 bytes, checksum: 64e3f161f474e81e2797c109d6c53dd5 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 誌謝 i
中文摘要 iii Abstract v 目錄 vii 圖目錄 xi 表目錄 xvii 縮寫與符號說明 xix 中英名詞對照 xxi 1. 緒論 1 1.1. 研究背景與動機 1 1.2. 研究組織架構 3 2. 文獻回顧 5 2.1. 幹細胞 5 2.1.1. 幹細胞之性質及分類 5 2.1.2. 間葉幹細胞 11 2.3. 間葉幹細胞 17 2.3.1. 人類骨髓間葉幹細胞株 17 2.3.2. 牙髓幹細胞 17 2.3.2.1. 牙髓組織 17 2.3.2.2. 人類乳牙牙髓幹細胞 18 2.3.3. 間葉幹細胞之骨分化 21 2.4. 生醫材料 23 2.4.1. 幾丁聚醣 24 2.4.2. 動物明膠 25 2.4.3. 維他命C 26 2.4.4. 幹細胞培養於幾丁聚醣材料上之相關研究 27 2.4.5. 幹細胞培養於動物明膠材料上之相關研究 28 2.4.6. 幹細胞培養於幾丁聚醣-動物明膠複合材料上之研究 28 2.4.7. 骨組織及骨成型機制 29 3. 實驗材料、儀器及方法 31 3.1. 實驗材料 31 3.1.1. 生醫材料 31 3.1.2. 細胞培養所需材料 31 3.1.3. 細胞培養一般耗材 32 3.1.4. FDA / PI雙色螢光染色法 32 3.1.5. 抽取細胞之DNA之試劑 33 3.1.6. 抽取細胞之總RNA之試劑 33 3.1.7. 細胞之總蛋白質定量試劑 33 3.1.8. 反轉錄聚合酶連鎖反應所用之材料 33 3.1.9. DNA電泳 34 3.1.10. 免疫染色試劑 35 3.1.11. 鹼性磷酸酶活性測定之試劑 35 3.1.12. 流式細胞分析技術之試劑 35 3.1.13. Alizarin red S染色試劑 36 3.1.14. 鈣離子定量之試劑 36 3.2. 實驗儀器 36 3.3. 實驗原理與方法 38 3.3.1. 細胞培養基材之製備 38 3.3.2. 所使用細胞株及培養條件 39 3.3.3. 細胞繼代培養於十二孔盤 39 3.3.4. 流式細胞分析技術 40 3.3.5. 免疫染色 40 3.3.6. FDA / PI雙色螢光染色法 41 3.3.7. 細胞總DNA之抽取 41 3.3.8. 細胞總RNA的抽取 42 3.3.9. 細胞總蛋白質含量測定 42 3.3.10. 細胞特定基因表現量:two step RT-PCR及DNA電泳 43 3.3.11. 鹼性磷酸酶活性之測定 44 3.3.12. 骨鈣素之流式細胞分析技術 44 3.3.13. Alizarin red S 染色 45 3.3.14. 鈣含量測定 45 3.3.15. 材料機械強度測試 46 4. 結果與討論 47 4.1. 間葉幹細胞性質與增生能力探討 47 4.1.1. 細胞表面抗原之流式細胞儀分析 47 4.1.2. 免疫染色 51 4.1.3. 各種生醫材料上之細胞培養 58 4.2. 生醫材料對間葉幹細胞骨分化能力影響 65 4.2.1. 特定基因表現量 65 4.2.2. 細胞鹼性磷酸酶之活性探討 75 4.2.3. 骨鈣素之蛋白質表現 80 4.2.4. Alizarin Red S染色 89 4.2.5. 鈣含量之測定 93 4.3. 幾丁聚醣�動物明膠薄膜之機械性質 97 4.4. 綜合討論 99 5. 結論 104 5.1. 結論 104 5.2. 未來展望 106 參考文獻 107 | |
dc.language.iso | zh-TW | |
dc.title | 動物明膠/維他命C/幾丁聚醣複合材料
對於骨髓及牙髓幹細胞骨分化潛能之效應 | zh_TW |
dc.title | Effects of Gelatin/Ascorbic acid/Chitosan Composite
Materials on the Osteogenic Differentiation of Bone Marrow Stromal Cells and Stem Cells from Human Exfoliated Deciduous Teeth | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 王盈錦,李伯訓 | |
dc.subject.keyword | 幾丁聚醣,動物明膠,維他命C,人類乳牙牙髓幹細胞,骨髓間葉幹細胞株,骨分化,生醫材料, | zh_TW |
dc.subject.keyword | chitosan,gelatin,ascorbic acid,stem cells from human exfoliated deciduous teeth,bone marrow stromal cells,osteogenic differentiation,biomaterials, | en |
dc.relation.page | 121 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-08-20 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 化學工程學研究所 | zh_TW |
顯示於系所單位: | 化學工程學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 4.15 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。